GW VRU tests Pfizer's new vaccine for C. diff

Press Releases
GW's David Diemert interviews for Beacon Magazine

Our director, Dr. David Diemert, recently interviewed with the Beacon Newspaper providing information on a new Pfizer study for C. diff, a bacterial infection that causes severe diarrhea. Click this link to get to the hompage: 

https://www.thebeaconnewspapers.com/

Check out the Washington Metro edition and the interview is on page 6!

 

Enrollment is still open for this study, you can find the link to the interest survey here:

https://redcap.link/gwvru-cdiff

 

vaccine

Latest News

Ebola virus
A new Ebola outbreak is confirmed in a remote Congo province, with 65 deaths recorded
Health officials have confirmed a new Ebola outbreak in the Democratic Republic of Congo’s Ituri province, where at least 65 people have died and 246 suspected cases have been identified. Authorities are especially concerned because the outbreak may involve a non-Zaire strain of the virus, meaning…
Picture of small pox with the outer and inner core
Results show safety and immunogenicity of fractional doses of the MVA-BN mpox vaccine
This was a phase 2, randomized, open-label, non-placebo controlled trial to evaluate two partial doses o the Modified Vaccinia Ankara-Bavarian Nordin (MVA-BN) vaccine for protection against mpox.
Lassa Virus under a microscope
Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate
This was a phase 1, double-blind trial to examine the safety and immunogenicity of a replication-competent recombinant vesicular stomatitis virus-vectored vaccine to reduce the risk of infection and severe illness from Lassa Fever.